Occam is pleased to announce Jorgen Hansen, a seasoned medtech veteran, as the new CEO at Ivenix as the company prepares to bring its next-generation infusion pump to the market.
Jorgen arrives at the company at a critical inflection point after securing 510(k) clearance from the FDA in June 2019. The large-volume device was designed with a streamlined digital management system to help reduce medication errors and potential patient harm.
Before Ivenix, Hansen held multiple roles at Cantel Medical Corporation over the past seven years, most recently as president and CEO. Prior to that, he was senior VP of global strategy, marketing and innovation at ConvaTec, and a senior VP of global operations at Coloplast. He also serves on the board of the industry trade association AdvaMed.